DrugMapper


Synonyms:	3,5,4'-Trihydroxy-trans-stilbene BIA 6-512 BIA-6-512 Biofort Ca 1201 Cuspidatin (e)-resveratrol Melinjo resveratrol 20 NSC-327430 Polygonin Resveratrol Resveratrol(e)-form Resveratrol p 5 Resvida Srt 501m Trans-resveratrol
Status:	Approved
Entry Type:	Small molecule
Molecule Category:	UNKNOWN
UNII:	Q369O8926L


InChI Key	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
Smile	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1
InChI	InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+

Property Name	Value
Molecular Formula	C14H12O3
Molecular Weight	228.25
AlogP	2.97
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	2.0
Polar Surface Area	60.69
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	17.0

Targets	EC50(nM)	IC50(nM)	Kd(nM)	Ki(nM)	Inhibition(%)
Enzyme Cytochrome P450 Cytochrome P450 family 1 Cytochrome P450 family 1A Cytochrome P450 1A1	-	11000-34000	-	-	-
Enzyme Cytochrome P450 Cytochrome P450 family 1 Cytochrome P450 family 1B Cytochrome P450 1B1	-	1400-55000	-	750-11200	-
Enzyme Cytochrome P450 Cytochrome P450 family 19 Cytochrome P450 family 19A Cytochrome P450 19A1	-	25000-25400	-	41670	35-63
Enzyme Cytochrome P450 Cytochrome P450 family 3 Cytochrome P450 family 3A Cytochrome P450 3A4	-	-	-	20000	-
Enzyme Hydrolase	-	-	-	-	0
Enzyme Kinase Protein Kinase AGC protein kinase group AGC protein kinase PKC family AGC protein kinase PKC alpha subfamily	-	-	-	-	5
Enzyme Kinase Protein Kinase AGC protein kinase group AGC protein kinase SGK family	-	-	-	-	50
Enzyme Kinase Protein Kinase Atypical protein kinase group Atypical protein kinase BCR family	-	28000	-	-	-
Enzyme Kinase Protein Kinase STE protein kinase group STE protein kinase STE20 family STE protein kinase PAKA subfamily	-	15000	-	-	-
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase Abl family	-	28000	-	-	-
Enzyme Lyase	-	19000	-	2210	-
Enzyme Oxidoreductase	-	450-6900	11700	88	10-90
Enzyme Protease Aspartic protease Aspartic protease AA clan Aspartic protease A1A subfamily	-	-	-	-	41
Enzyme Protease Serine protease Serine protease SC clan Serine protease S9B subfamily	-	1	-	-	-
Enzyme Transferase	-	250	-	-	-
Enzyme	-	450-6900	11700	750-11200	10-90
Epigenetic regulator Eraser Histone deacetylase HDAC class III	23600-87200	-	-	-	-
Epigenetic regulator Eraser Lysine demethylase Lysine-specific demethylase	-	10200	-	-	-
Ion channel Voltage-gated ion channel Transient receptor potential channel	-	750-19900	-	-	-4-38
Membrane receptor Family A G protein-coupled receptor Small molecule receptor (family A GPCR) Monoamine receptor Adrenergic receptor	-	19950	-	-	-
Membrane receptor	-	1100-16800	38500	-	30-80
Other cytosolic protein	-	2500	-	-	-
Secreted protein	-	-	470	-	94
Transcription factor Nuclear receptor Nuclear hormone receptor subfamily 3 Nuclear hormone receptor subfamily 3 group A Nuclear hormone receptor subfamily 3 group A member 1	-	-	-	785	-
Transcription factor	5400	2500	-	169	-
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides	-	-	-	-	117
Transporter Primary active transporter ATP-binding cassette ABCB subfamily	-	60000	-	-	-
Unclassified protein	-	21900-21900	-	-	-

Mesh Heading	Maximum Phase	Mesh ID	Reference
Pulmonary Disease, Chronic Obstructive	3	D029424	ClinicalTrials
Osteoarthritis	3	D010003	ClinicalTrials
Rhinitis, Allergic, Seasonal	3	D006255	ClinicalTrials
Huntington Disease	3	D006816	ClinicalTrials
Renal Insufficiency, Chronic	3	D051436	ClinicalTrials
Cardiomyopathy, Dilated	3	D002311	ClinicalTrials
Infertility	3	D007246	ClinicalTrials
Inflammation	3	D007249	ClinicalTrials
Metabolic Syndrome	3	D024821	ClinicalTrials
Peripheral Arterial Disease	3	D058729	ClinicalTrials
Polycystic Ovary Syndrome	2	D011085	ClinicalTrials
Alzheimer Disease	2	D000544	ClinicalTrials
Schizophrenia	2	D012559	ClinicalTrials
Diabetes Mellitus, Type 2	2	D003924	ClinicalTrials
Insulin Resistance	2	D007333	ClinicalTrials
Aging	2	D000375	ClinicalTrials
Paraplegia	2	D010264	ClinicalTrials
Hypercholesterolemia	2	D006937	ClinicalTrials
Lymphangioleiomyomatosis	2	D018192	ClinicalTrials
Friedreich Ataxia	2	D005621	ClinicalTrials
Non-alcoholic Fatty Liver Disease	2	D065626	ClinicalTrials
Lymphoma, Follicular	2	D008224	ClinicalTrials
Severe Acute Respiratory Syndrome	2	D045169	ClinicalTrials
Severe Acute Respiratory Syndrome	2	D045169	ClinicalTrials
Cardiovascular Diseases	1	D002318	ClinicalTrials
Hypertension	1	D006973	ClinicalTrials
Colonic Neoplasms	1	D003110	ClinicalTrials
Colorectal Neoplasms	1	D015179	ClinicalTrials
Parkinson Disease	1	D010300	ClinicalTrials
Memory Disorders	1	D008569	ClinicalTrials
Rectal Neoplasms	1	D012004	ClinicalTrials
Liver Neoplasms	1	D008113	ClinicalTrials
Brain Concussion	1	D001924	ClinicalTrials
Neoplasms	1	D009369	ClinicalTrials
Diabetes Mellitus, Type 1	0	D003922	ClinicalTrials
Diabetic Nephropathies	0	D003928	ClinicalTrials

Scaffolds

Target Level :

Level 3

Level 4

Level 5

Level 6

Extend network:

Indication

Mechanism of Action

Primary Target

Target Level

Cross References

Resources	Reference
CAS NUMBER	501-36-0
ChEBI	45713
ChEMBL	CHEMBL165
DrugBank	DB02709
EPA CompTox	DTXSID4031980
FDA SRS	Q369O8926L
Human Metabolome Database	HMDB0003747
Guide to Pharmacology	8741
KEGG	C03582
PDB	STL
PharmGKB	PA165291838
PubChem	445154
SureChEMBL	SCHEMBL19425
ZINC	ZINC000000006787

RESVERATROL

Structure

Physicochemical Descriptors

Pharmacology

Indications

Related Entries

Scaffolds

Cross References


Active Pharmaceutical Ingredients (APIs) Scaffolds	Exact Similarity SubStructure	Threshold (%) >= 70